These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11173869)

  • 1. Some problems in the genetics of X-linked mental retardation.
    Tariverdian G; Vogel F
    Cytogenet Cell Genet; 2000; 91(1-4):278-84. PubMed ID: 11173869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific X-linked mental retardation: background, types, diagnosis and prevalence.
    Howard-Peebles PN
    J Ment Defic Res; 1982 Dec; 26 (Pt 4)():205-13. PubMed ID: 6763078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9th international workshop on fragile X syndrome and X-linked mental retardation.
    Fryns JP; Borghgraef M; Brown TW; Chelly J; Fisch GS; Hamel B; Hanauer A; Lacombe D; Luo L; MacPherson JN; Mandel JL; Moraine C; Mulley J; Nelson D; Oostra B; Partington M; Ramakers GJ; Ropers HH; Rousseau F; Schwartz C; Steinbach P; Stoll C; Tranebjaerg L; Turner G; Van Bokhoven H; Vianna-Morgante A
    Am J Med Genet; 2000 Oct; 94(5):345-60. PubMed ID: 11050616
    [No Abstract]   [Full Text] [Related]  

  • 4. Seventh International Workshop on the Fragile X and X-linked Mental Retardation.
    Tranebjaerg L; Lubs HA; Borghgraef M; Brown WT; Fisch G; Fryns JP; Hagerman R; Jacobs PA; Mandel JL; Mulley J; Oostra B; Schwartz C; Sherman S; Willard H; Willems P
    Am J Med Genet; 1996 Jul; 64(1):1-14. PubMed ID: 8826442
    [No Abstract]   [Full Text] [Related]  

  • 5. X-linked mental retardation. Conference report: Fourth International Workshop on the fragile X and X-linked mental retardation.
    Am J Med Genet; 1991; 38(2-3):153. PubMed ID: 1673295
    [No Abstract]   [Full Text] [Related]  

  • 6. Fragile X syndrome: a major cause of X-linked mental retardation.
    Butler MG
    Compr Ther; 1988 Jul; 14(7):3-7. PubMed ID: 3060303
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrence risks in mental retardation.
    Crow YJ; Tolmie JL
    J Med Genet; 1998 Mar; 35(3):177-82. PubMed ID: 9541099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conference report: Fourth International Workshop on the fragile X and X-linked mental retardation.
    Brown WT; Jenkins E; Neri G; Lubs H; Shapiro LR; Davies KE; Sherman S; Hagerman R; Laird C
    Am J Med Genet; 1991; 38(2-3):158-72. PubMed ID: 1673296
    [No Abstract]   [Full Text] [Related]  

  • 9. Breakthroughs in molecular and cellular mechanisms underlying X-linked mental retardation.
    Chelly J
    Hum Mol Genet; 1999; 8(10):1833-8. PubMed ID: 10469834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FMR2 gene, FRAXE and non-specific X-linked mental retardation: clinical and molecular aspects.
    Gecz J
    Ann Hum Genet; 2000 Mar; 64(Pt 2):95-106. PubMed ID: 11246464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6th International Workshop on the Fragile X and X-Linked Mental Retardation. Cairns, Northern Australia, 3-6 August 1993. Proceedings and abstracts.
    Am J Med Genet; 1994 Jul; 51(4):281-618. PubMed ID: 7942988
    [No Abstract]   [Full Text] [Related]  

  • 12. Rett-like syndrome in fragile X syndrome.
    Alembik Y; Dott B; Stoll C
    Genet Couns; 1995; 6(3):207-10. PubMed ID: 8588847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that a dodecamer duplication in the gene HOPA in Xq13 is not associated with mental retardation.
    Friez MJ; Essop FB; Krause A; Castiglia L; Ragusa A; Sossey-Alaoui K; Nelson RL; May MM; Michaelis RC; Srivastava AK; Schwartz CE; Stevenson RE; Goldman A; Villard L; Longshore JW
    Hum Genet; 2000 Jan; 106(1):36-9. PubMed ID: 10982179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomenclature guidelines for X-linked mental retardation.
    Mulley JC; Kerr B; Stevenson R; Lubs H
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):383-91. PubMed ID: 1605216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked mental retardation: caveats in genetic counselling.
    Partington MW
    Am J Med Genet; 1986; 23(1-2):101-9. PubMed ID: 3953640
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular-clinical spectrum of the ATR-X syndrome.
    Gibbons RJ; Higgs DR
    Am J Med Genet; 2000; 97(3):204-12. PubMed ID: 11449489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome.
    Hammer S; Dorrani N; Dragich J; Kudo S; Schanen C
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):94-8. PubMed ID: 12112734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XLMR genes: update 1992.
    Neri G; Chiurazzi P; Arena F; Lubs HA; Glass IA
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):373-82. PubMed ID: 1605215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-specific X linked mental retardation.
    Kerr B; Turner G; Mulley J; Gedeon A; Partington M
    J Med Genet; 1991 Jun; 28(6):378-82. PubMed ID: 1870094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group.
    de Vries BB; Mohkamsing S; van den Ouweland AM; Mol E; Gelsema K; van Rijn M; Tibben A; Halley DJ; Duivenvoorden HJ; Oostra BA; Niermeijer MF
    J Med Genet; 1999 Jun; 36(6):467-70. PubMed ID: 10874635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.